Company News
21 Apr 2026
Lumos Diagnostics recently hosted an investor webinar covering its Q3 FY26 financial results and operational progress.
In this session, Lumos Chairman Sam Lanyon, CEO Doug Ward and CFO Barrie Lambert provided an update on the early US rollout activity following CLIA waiver, as well as broader operational developments.
A few more pieces along the same thread. See the full index for everything.
COMPANY NEWS
1 min read
Lumos CEO Doug Ward, Lumos Chief Commercial Officer Paul Kase, Lumos Director of U.S. Sales
COMPANY NEWS
2 min read
FebriDx® has surpassed 100 healthcare locations across 18 states in the United States
COMPANY NEWS
1 min read
Lumos has achieved enrolment of 250 patients in its BARDA-funded FebriDx® paediatric clinical study, triggering a US$670,000 milestone payment...